Navigation Links
Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
Date:5/10/2013

NEW YORK, May 10, 2013 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a securities class action has been commenced in the United States District Court for the District of Massachusetts on behalf of a class (the "Class") of purchasers of Aveo Pharmaceutical, Inc. ("Aveo" or the "Company") (NASDAQ: AVEO) securities between January 3, 2012 and May 1, 2013 (the "Class Period").

Aveo is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapies.  The Company's lead product is an oral inhibitor of the vascular endothelial growth factor ("VEGF") receptors.

The Complaint alleges that throughout the Class Period, Defendants conditioned investors to believe that the Company's drug Tivopath (or Tivozanib) would receive approval from the U.S. Food and Drug Administration ("FDA") through a host of materially false and misleading statements regarding its Phase III ("TIVO-1") trial design and results.  Specifically, the Company (a) failed to disclose to investors that the FDA had recommended that the Company conduct an additional Phase III trial due to adverse trends in the Company's first study; (b) misled investors regarding the overall safety and efficacy of the product, including failing to disclose the 25% higher rate of death associated with Tivozanib therapy compared to the control drug, Sorafenib; and (c) failed to disclose that almost 90% of the patients studied in TIVO-1 were enrolled from sites in Central and Eastern Europe with inconsistent treatment patterns from those in the U.S.  As a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On April 30, 2013, the FDA released its Oncologic Drugs Advisory Committee ("ODAC")
'/>"/>

SOURCE Bernstein Liebhard LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
2. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
3. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014 AVACEN Medical announced today ... 510 (k) OTC clearance by the U.S. Food and ... be marketed over the Internet for: the temporary ... and minor strains and sprains . Logo ... 100 (MSRP $2495) is a sophisticated medical device incorporating ...
(Date:10/22/2014)... 2014  With a vision to ensure safety ... Global Pharmaceutical and Biotech manufacturer selects and implements ... solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... aggregated by the Xyntek and Antares solution is ...
(Date:10/22/2014)...  Early symptoms of diabetic eye and vision ... technology, coupled with yearly, comprehensive eye exams, are ... of eye diseases, including those associated with diabetes, ... untreated, these diseases can potentially lead to vision ... optometric researchers have deployed a new tool that ...
Breaking Medicine Technology:AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Xyntek and Antares Serialization Solution Protects Pets Too! 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... today, at the American Psychiatric Association Annual Meeting in ... Psychiatry at UCLA, and a Senior Medical Advisor to ... open-label clinical trial that studied the effects of eTNS™ ... an adjunct to pharmacotherapy.  Results from the 17-question Hamilton ...
... Inc. is pleased to announce that Bio AMD Limited, ... the "Company" OTCBB: BIAD.OB, OTCQB: BIAD) has submitted a ... Cartridge Test Cap ("Cap") component used in its Digital ... in pregnancy and ovulation testing applications, typically require a ...
Cached Medicine Technology:Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Bio-AMD, Inc.; Patent Application for Cartridge Test Cap 2Bio-AMD, Inc.; Patent Application for Cartridge Test Cap 3
(Date:10/25/2014)... -- Not getting the right amount of sleep might ... suggests. Those who sleep less or more than ... be more prone to developing the chronic condition, which ... authors concluded that duration and quality of sleep are ... bowel diseases. "Both short and long durations of ...
(Date:10/25/2014)... Randy Dotinga HealthDay ... As more genetic tests are developed that spot increased risks ... be more proactive about getting screened. But a new ... not change behavior: People who found out their genes doubled ... people with average risk to get screened. "It didn,t ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 On October ... Minds featuring skin diseases both fictional and real. ... (CEHMDF), a nonprofit organization committed to advocacy and philanthropy ... CBS will take the opportunity to impart truth and ... , There are many misconceptions about Morgellons ...
(Date:10/22/2014)... Amy Norton HealthDay Reporter ... remain riveted on the three Ebola cases in Dallas. But, ... health threat to Americans. President Barack Obama on Friday ... the virus, which has infected two Dallas nurses who cared ... at Texas Health Presbyterian Hospital. But the U.S. cases ...
(Date:10/22/2014)... 2014 Hay House is pleased to announce ... Upgrade Your Life (Paperback; $10.82) written by the highly esteemed ... This book is meant to help readers of all ... recovery. , Recovery 2.0 is not the average self-help ... is a guide for what comes next. For ...
Breaking Medicine News(10 mins):Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3
... partners improving the quality of patient ... care using Microsoft technology., ... Microsoft Corp. today announced the winners of the,11th annual MS-HUG ... have been awarded to healthcare organizations, software,vendors and system integrators ...
... Feb. 26 Hospira, Inc.,(NYSE: HSP ... today announced a,new national agreement with HealthTrust ... provide HealthTrust member organizations with,access, on a ... related sets and disposables, along with intravenous,(I.V.) ...
... 26 February. Speciality European Pharma (SEP) today announced ... to treat advanced and metastatic hormone responsive prostate cancer ... testosterone levels, thereby giving quick control of prostate cancer ... can choose to either keep the patient on Plenaxis® ...
... Dramatically Improves Protection and Availability of Critical Patient ... and Archiving, HOPKINTON, Mass., Feb. 26 ... in information infrastructure solutions, today announced,that Norton Healthcare, ... the top 100 integrated healthcare delivery systems in ...
... Calif., Feb. 26 HASP Online announces,JSABuilder ( ... for,conducting Job Safety Analysis (JSA)., JSA, also ... proven and effective,technique of identifying potential job hazards ... them. The Occupational Health and,Safety Administration (OSHA) recommend ...
... About Medicare, Health Insurance Options, KANSAS CITY, ... boomers turn 62 this year and begin claiming ... the National Association of Insurance,Commissioners (NAIC), many are ... Medicare eligibility., The NAIC,s national survey of ...
Cached Medicine News:Health News:Microsoft and Microsoft Healthcare Users Group Announce Winners of MS-HUG Healthcare Innovation Awards 2008 2Health News:Microsoft and Microsoft Healthcare Users Group Announce Winners of MS-HUG Healthcare Innovation Awards 2008 3Health News:Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment 2Health News:Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment 3Health News:Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure 2Health News:Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure 3Health News:Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure 4Health News:HASP Online Provides Free Job Safety Analysis Tool Available Online 2Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 2Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 3Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 4Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 5Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 6
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
... The WideBiter Punch series facilitates fast ... recreating a smooth, anatomically shaped meniscal rim. ... low profile to access even the tightest ... Arthrex California, Inc., 20 years of engineering ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
Medicine Products: